| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |